Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: A doseresponse study

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 3, 1998, Pages 312-319

  Aaronson, Donald ^a   Kaiser, Harold ^b   Dockhorn, Robert ^c   Findlay, Steven ^d   Korenblat, Philip ^e   Thorsson, Lars ^f   Källén, Anders ^a  

^a Aaronson Asthma and Allerg Assoc   (United States)

^b Allergy and Asthma Specialists   (United States)

^c International Medical Technical Consultants Inc

^d HealthQuest Research   (United States)

^e Barnes Jewish West County Hospital   (United States)

^f ASTRAZENECA R AND D   (Sweden)

Author keywords

Asthma; Budesonide; Corticosteroids; HPA axis; Turbuhaler

Indexed keywords

BUDESONIDE; PREDNISONE;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

EID: 0031944957     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70241-6     Document Type: Article

References (27)

1. Toogood JH, Prankish CW, Jennings BH, Baskerville JC, Borgâ O, Lefcoe NM, et al. A study of the mechanism of the antiasthmatic action of inhaled budesonide. J Allergy Clin Immunol 1990;85:872-80.
2. Reed CE. Aerosol steroids as primary treatment of mild asthma. N Engl J Med 1991;325:425-6.
3. Brattsand R, Thalén A, Roempke K, Källström L, Gruvstad E. New glucocorticoids with improved ratio between topical and systemic activities. Eur J Respir Dis 1982;122(suppl):62-73.
4. Ellul-Micallef R, Hansson E, Johansson SA. Budesonide: a new corticosteroid in bronchial asthma. Eur J Respir Dis 1980;61:167-73.
5. Ellul-Micallef R, Hansson E, Johansson SA. Acute dose-response studies in bronchial asthma with a new corticosteroid, budesonide. Br J Clin Pharmacol 1983;15:419-22.
6. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Comparison of a -agonist, terbutaline, with an inhaled corticosteroid, budesonide in newly detected asthma. N Engl J Med 1991;325:388-92.
7. Brattsand R, Pipkorn U. Glucocorticoids: experimental approaches. In: Kaliner MA, Barnes PJ, Persson CGA, editors. Asthma: its pathology and treatment. New York: Marcel Dekker Inc.; 1991. p. 667-709.
8. Dahlberg E, Thalén A, Brattsand R, Gustafsson JA, Johansson U, Roempke K, et al. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16-alpha, 17-alpha-acetal substituted glucocorticosteroids. Mol Pharmacol 1984;25:70-8.
9. Edsbäcker S, Jönsson S, Lindberg C, Ryrfeldt À, Thalén A. Metabolic pathways of the topical glucocorticoid budesonide in man. Drug Metab Dispos 1983;11:590-6.
10. Grahnén A, Brundin RM, Ling-Anderson A, Lönnebo A, Eckernäs S-A. The systemic potency of fluticasone propionate from Diskhaler vs budesonide from Turbuhaler. Eur J Clin Pharmacol 1997;52: 261-7.
11. Brogden RN, McTavish D. Budesonide, an updated review of its pharmacological properties and therapeutic efficacy in asthma and rhinitis. Drugs 1992;44:375-407.
12. Boorsma M, Andersson N, Larsson P, Ullman A. Assessment of the relative systemic potency of inhaled fluticasone and budesonide. Eur Respir J 1996;9:1427-32.
13. Streeten DHP, Anderson GH, Dalakos TG, Seeley D, Mallov JS, Eusebio R, et al. Normal and abnormal hypothalamic-pituitaryadrenocortical system in man. Endocr Rev 1984;5:371-94.
14. Feiss G, Morris R, Rom D, Mansfield L, Dockhorn R, Ellis E, et al. A comparative study of the effects of intranasal triamcinolone acetonide aerosol (ITAA) and prednisone on adrenal cortical function. J Allergy Clin Immunol 1992;89:1151-6.
15. Kellerman D, Stricker W, Howland W, Sorkness C, Dockhorn R, Galant S, et al. Effects of inhaled fluticasone propionate (FP) on the HPA axis of patients with asthma [abstract]. Eur Respir J 1996; 9(suppl 23):162.
16. Sorkness C, Howland W, Stricker W, Tita J, Noveck R, Dockhorn R, et al. Comparison of inhaled fluticasone propionate (FP) and triamcinolone acetonide (TAA) effects on the HPA axis as assessed by 6-hour cosyntropin infusion testing [abstract]. Eur Respir J 1996;9(suppl 23): 163.
17. LaForce C, Goldstein M, Storms W, Levy B, Li J, Littlejohn T, et al. Comparison of inhaled fluticasone propionate (FP) and flunisolide (FLN) effects on the HPA axis as assessed by 6-hour cosyntropin infusion testing [abstract]. Eur Respir J 1996;9(suppl 23):163.
18. Thorsson L, Edsbäcker S, Conradson T-B. Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler, P-MDI. Eur Respir J 1994;7:1839-44.
19. Van den Berg JHM, Mol ChR, Decider RS, Thijssen JHH. A quantitative assay of Cortisol in human plasma by high performance liquid chromatography using a selective chemically bonded stationary phase. Clin Chim Acta 1977;78:165-72.
20. Busse W. Dose-related efficacy of Pulmicort (budesonide) Turbuhaler in moderate to severe asthma. J Allergy Clin Immunol 1998. In press.
21. Toogood JH, Baskerville JC, Jennings B, Lefcoe NM. Johansson S-A. Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 1989;84:688-700.
22. Toogood J, Jennings B, Hodsman A, Baskerville J, Fraher L. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991;88:572-80.
23. Padfield PL, Teelucksingh S. Inhaled corticosteroids: the endocrinologist's view. Eur Respir Rev 1993;3:494-500.
24. Ebden P, Jenkins A, Houston G, Davies BH. Comparison of two high-dose aerosol corticosteroid treatments, beclomethasone diproprionate (1500 fjig/day) and budesonide (1600 fjig b.i.d.), for chronic asthma. Thorax 1986;41:869-74.
25. Laursen LC, Tandorf E, Weeke B. High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. Eur J Respir Dis 1986;68:19-28.
26. Nelson H. Steroid sparing effect of Pulmicort (budesonide) Turbuhaler in patients with chronic oral steroid-dependent asthma. Chest 1998. In Press.
27. Corren J, Rachelefsky G, Hochhaus G. A five-way parallel randomized study to compare the safety profile of beclomethasone dipropionate (BDP), budesonide (BUD), flunisolide (FLU), fluticasone propionate (FP), and triamcinolone acetonide (TA) in healthy male volunteers [abstract]. Chest 1996;110(suppl):83.